DCT and neoplasm: As previous studies have demonstrated, Ad-DCT is able to prime a DCT specific T cell immune response and protect mice from a B16 tumor challenge or tumor re-growth (87, 88), but has limited efficacy in a therapeutic model of lung metastases (89).